Three Former Executives for Magellan Diagnostics Plead Guilty to False Statements and FDCA Violations
BOSTON – The former CEO, COO and Director of Quality Assurance and Regulatory Affairs for Magellan Diagnostics, Inc. (Magellan), a medical device company headquartered in Billerica, Mass., have pleaded guilty in connection with concealing a device malfunction that produced inaccurately low lead test results for thousands of children and other patients. The defendants were indicted by a federal grand jury in April 2023.
Action Details
- Date:March 11, 2025
- Agency:U.S. Attorney's Office, District of Massachusetts
-
Enforcement Types:
- Criminal and Civil Actions